TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
19 hedge funds and large institutions have $2.12M invested in TFF Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
14% less capital invested
Capital invested by funds: $2.45M → $2.12M (-$336K)
17% less funds holding
Funds holding: 23 → 19 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$203K |
| 2 |
Renaissance Technologies
New York
|
+$11.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.69K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$207K |
| 2 |
JP Morgan Chase
New York
|
-$6.97K |
| 3 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$6.01K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.69K |
| 5 |
OP
ORG Partners
Roanoke,
Indiana
|
-$5.19K |
TFFP Hedge Fund Activity: Q1 2024 in Review
19 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2024, worth a combined $2.12M — down 14% from $2.45M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TFFP and 1 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Westside Investment Management, adding an estimated $203K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $207K sold.
- 19 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2024, down from 23 in Q4 2023.
- Funds reported $2.12M of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2024, down 14% quarter-over-quarter.
- 1 fund opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2024 and 5 closed out, a net change of -4 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q1 2024 was Westside Investment Management, an estimated $203K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2024 was AIGH Capital Management, an estimated $207K sold.
Based on aggregated 13F filings for Q1 2024.